Sign in →

Test Code LAB5122 Mumps Virus Antibody, IgM and IgG, Serum

Important Note

Mayo's test code: MMPGM

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Reporting Name

Mumps Ab, IgM and IgG, S

Specimen Type

Serum


Specimen Required


Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions: Centrifuge and aliquot serum into plastic vial.


Reject Due To

Gross hemolysis Reject
Gross lipemia Reject
Heat-inactivated specimen Reject

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 14 days
  Frozen  14 days

Specimen Minimum Volume

0.9 mL

Day(s) Performed

MMPM: Tuesday

MPPG: Monday through Saturday

Specimen Retention Time

14 days

Report Available

1 to 7 days

Reference Values

IgM:

Negative: Index value 0.00-0.79

Reference value applies to all ages.

 

IgG:

Vaccinated: Positive (≥1.1 AI)

Unvaccinated: Negative (≤0.8 AI)

Reference values apply to all ages.

Useful For

Diagnosis of mumps virus infection

 

Determination of postimmunization immune response of individuals to the mumps vaccine

 

Documentation of previous infection with mumps virus in an individual with no previous record of immunization to mumps virus

CPT Code Information

86735-Mumps, IgG

86735-Mumps, IgM

LOINC Code Information

Test ID Test Order Name Order LOINC Value
MMPGM Mumps Ab, IgM and IgG, S 77250-9

 

Result ID Test Result Name Result LOINC Value
MUMP1 Mumps Ab, IgM, S 6478-2
MUMG Mumps Ab, IgG, S 6476-6
DEXM Index Value 25419-3
DEXG5 Mumps IgG Antibody Index 25418-5

Profile Information

Test ID Reporting Name Available Separately Always Performed
MMPM Mumps Ab, IgM, S Yes Yes
MPPG Mumps Ab, IgG, S Yes Yes

Supportive Data

IgM:

The SeraQuest mumps IgM kit showed a sensitivity of 97.3% and a specificity of 96.6% when 160 specimens were tested in parallel with a reference method.(Package insert: SeraQuest)

 

IgG:

To evaluate the accuracy of the BioPlex Mumps IgG multiplex flow immunoassay (MFI), 500 prospective serum specimens were analyzed in a blinded fashion by the SeraQuest Mumps IgG enzyme immunoassay (EIA) and the BioPlex Mumps IgG assay. Specimens with discordant results after initial testing were repeated by both assays during the same freeze/thaw cycle. Further discrepancies were evaluated by the Mumps IgG VIDAS enzyme-linked fluorescent immunoassay (ELFA; bioMerieux, Inc). The results are summarized below:

 

 

SeraQuest Mumps IgG EIA

BioPlex Mumps IgG

 

Positive

Negative

Equivocal

Positive

412

4(a)

8

Negative

3(b)

48

3

Equivocal

5

6

11

 

(a) All 4 of these samples tested positive by VIDAS Mumps IgG ELFA

(b) One of these 3 samples tested negative by the VIDAS Mumps IgG ELFA

Sensitivity: 98.1% (412/420); 95% Confidence Intervals (CI): 96.2%-99.1%

Specificity: 82.8% (48/58); 95% CI: 70.9%-90.6%

Overall Percent Agreement: 94.2% (471/500); 95% CI: 91.8%-96.0%

Forms

If not ordering electronically, complete, print, and send Infectious Disease Serology Test Request (T916) with the specimen.